Prelude Therapeutics Incorporated · NASDAQ:PRLD

Baker Bros. Advisors LP reported a 15.50% stake in Prelude Therapeutics Incorporated (Schedule 13D/A)

Event Apr 20, 2026 · Filed Apr 22, 2026

Baker Bros. Advisors LP reported a 15.50% stake in Prelude Therapeutics Incorporated, 10,295,301 shares, with active intent on Apr 20, 2026. Filed Apr 22, 2026 (Schedule 13D/A).

Stake
15.50%
Shares
10,295,301
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Baker Bros. Advisors LP15.50%10,295,301
Baker Bros. Advisors (GP) LLC15.50%10,295,301
Julian C. Baker15.50%10,295,301
Felix J. Baker15.50%10,295,301

Source

View original at SEC

Related